摘要
我们测定了160例MG病人血清β_2-m的含量,其均值明显高于正常对照组(P<0.01)。35例口服强的松后β_2-m的含量,较治疗前明显减低(P<0.01)。我们认为测定β_2-m是评价MG的免疫状态和药物疗效的实验指标之一。
Serum β_2-microglobulin (β_2-m) was measured in 160 cases of myasthenia gravis (MG). The results showed that the mean value of β_2-m in MG was obviously higher than in normal controls (P<0.01). There was significant difference of β_2-m levels before and after oral prednision treatment in 35 patients with MG.It was pointed out that the measurement of serum β_2-m may be considered as a reliable method for evaluating the immunological state and the effectiveness of medical treatment for patients with MG.
出处
《临床神经病学杂志》
CAS
1993年第2期87-88,共2页
Journal of Clinical Neurology
